Loading clinical trials...
Loading clinical trials...
According to the literature available pulmonary hypertension is present in 12 to 23% of patients suffering from Sjögren Syndrome. However epidemiological data are based on non-invasive measurements us...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Graz
NCT07333183 · Pulmonary Hypertension, Interstitial Lung Disease (ILD), and more
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07537517 · Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension (PH), and more
NCT06770023 · Lung Transplant, Pulmonary Hypertension
NCT07073820 · Pulmonary Hypertension
Medical University of Graz
Graz, Styria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions